Posted in | News | Biofuels

Blue Horizon Procures a Re-Newable Diesel Demonstration Plant

Blue Horizon Industries Inc. ("Blue Horizon" or the "Corporation") announced today that its wholly owned subsidiary Blue Horizon Bio-Diesel Inc ("BH Bio-Diesel") has successfully completed financing and the purchase of a re-newable diesel demonstration plant.

The Corporation also announces today that its wholly owned subsidiary Blue Horizon Energy Inc. ("BH Energy"), has sold working interests in three oil assets held by the BH Energy to an arm's length third party ( the "Purchaser") of Calgary Alberta. The Corporation sold an undivided 30% working interest in its Northern Alberta heavy oil property referred to as "the Normandville" property. In the same transaction agreement, the Corporation sold 100% of the working interest held in the "Haro" prospective property. In a separate transaction the Corporation sold 10% of the working interest held in the "Waskahigan" prospective property.

The Purchaser has paid total consideration of $1,178,052 to the Corporation for the oil assets.

The Corporation and BH Bio-Diesel entered into two short-term loan agreements for a total of $382,000. Both loans will be paid back in full by December 31, 2013. The details of the loan will not be disclosed in this press release. The funds will be used to purchase the re-newable diesel demonstration plant located in Reno, Nevada.

Don Allan, President and CEO of Blue Horizon said "It was important to diverse of our oil assets in order to concentrate on the development of the re-newable diesel business as well it allowed us to settle some debts in the oil company. The purchase of the plant, is a significant step forward in our business plan to be a major producer of re-newable diesel".

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.